Renal Denervation Technologies

Global Market Trajectory & Analytics

MCP14407

EXECUTIVE ENGAGEMENTS

POOL

5763
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

922
Interactions with Platform & by Email

PARTICIPANTS

173
Unique # Participated

VALIDATIONS

37
Responses Validated*

COMPANIES

13
Responses Validated*
* Login for a full stack data experience

DATE

MAY 2021

TABLES

40

PAGES

107

EDITION

8

PRICE

USD 4950

CODE

MCP14407


COMPETITIVE METRICS

COMPANY

D S N T

% *

Abbott Laboratories, Inc.

Ablative Solutions, Inc.

Boston Scientific Corporation

Brattea

Medtronic PLC

Mercator MedSystems, Inc.

Otsuka Medical Devices Co., Ltd.

ReCor Medical, Inc.

Renal Dynamics LLC

SoniVie

*Login to Participate & View Data Stacks
View 13 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Renal Denervation Technologies Market to Reach $745.7 Million by 2026

Renal denervation refers to a catheter-based interventional therapy wherein a catheter is placed into a patient`s renal artery to make way for the delivery of radiofrequency energy in order to ablate the nerves in the vessel wall of the renal arteries that regulate vasoconstriction. Such a position leaves the vessel to continuously remain in the widest open position to enable higher flow of blood to the kidneys, allowing more blood to be filtered and excess water to be removed helping lower hypertension. The demand for renal denervation systems is growing steadily led by increase in prevalence of hypertension, growing base of geriatric population, longer lasting effect of the renal denervation procedure and its minimal complications and faster recovery time. Meanwhile, technological advancements are helping in the development of alternative technologies such as micro-infusion-based renal denervation systems. The demand of these systems is expected to grow as more clinical trials are conducted to establish efficacy and cost-effectiveness of renal denervation procedure as against traditional surgeries.

Amid the COVID-19 crisis, the global market for Renal Denervation Technologies estimated at US$113.3 Million in the year 2020, is projected to reach a revised size of US$745.7 Million by 2026, growing at a CAGR of 37.3% over the analysis period. Radiofrequency Based, one of the segments analyzed in the report, is projected to grow at a 36.8% CAGR to reach US$729.9 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ultrasound Based segment is readjusted to a revised 39.2% CAGR for the next 7-year period. This segment currently accounts for a 22.4% share of the global Renal Denervation Technologies market. Radiofrequency, owing to efficiency, safety and minimal time taken, is the most commonly used renal denervation technology with a dominating market share. Key factor favoring increase in demand for ultrasound-based renal denervation is its ability to overcome the shortcomings of radiofrequency-based renal denervation. The ultrasound-based technology uses high-frequency sound waves to ablates the nerves without establishing any contact with the tissues resulting in minimal injury to the renal arteries.

The U.S. Market is Estimated at $35.8 Million in 2021, While China is Forecast to Reach $49.5 Million by 2026

The Renal Denervation Technologies market in the U.S. is estimated at US$35.8 Million in the year 2021. The country currently accounts for a 25.46% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$49.5 Million in the year 2026 trailing a CAGR of 50.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 30.9% and 35.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 35.6% CAGR while Rest of European market (as defined in the study) will reach US$71.9 Million by the end of the analysis period. Europe dominates market share, driven by increasing number of drug-resistant hypertension cases, greater research and development initiatives for developing efficient devices, and approval of advanced renal denervation devices. Another key market, growth in the US is expected to be driven by escalating uncontrolled hypertension cases and increasing petitions for product authorizations.

Micro-Infusion Based Segment to Reach $38.1 Million by 2026

Micro-infusion based renal denervation focuses on delivering agents at a specific site to denervate the renal artery in order to reduce the blood pressure of the patient. As the approach involves direct and non-systemic injection of therapeutic agents, the method tends to be safe and more effective. In the global Micro-Infusion Based segment, USA, Canada, Japan, China and Europe will drive the 33.5% CAGR estimated for this segment. These regional markets accounted for a combined market size of US$5.8 Million in the year 2020. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.5 Million by the year 2026.

SELECT PLAYERS

Medtronic Inc; Ablative Solutions, Inc.; Abbott Laboratories; Renal Dynamics Limited; Mercator MedSystems, Inc.; ReCor Medical, Inc.; Boston Scientific Corp.; Symple Surgical, Inc.; Terumo Corporation

SEGMENTS

» Technology (Radiofrequency Based, Ultrasound Based, Micro-Infusion Based)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Latin America » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Hypertension - A Chronic Disease
Impact of Covid-19 and a Looming Global Recession
EXHIBIT: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Covid-19 Causes Major Dent to a Growing Renal Denervation Technologies Market
A Prelude to Renal Denervation
The Evolution
Global Renal Denervation Technologies Market Set to Witness Rapid Growth
Developed Regions Dominate, Asia-Pacific Exhibits Fastest Growth
Europe – A Major Market
Radiofrequency Ablation Dominates the Market, Ultrasound to Register Fastest Growth
Radiofrequency Based Renal Denervation
Ultrasound Based Renal Denervation
Micro-Infusion Based Renal Denervation
Stringent Regulatory Environment
Growth Deterrents
Competitive Landscape
Select List of Approved Renal Denervation Devices
Symplicity Renal Denervation System Leads
Renal Denervation Devices
EnligHTN
Iberis
Paradise
Symplicity
Vessix (V2)
Recent Market Activity
Recent Clinical Trials in Nerve Denervation Technologies
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Incidence of Hypertension Drives the Market for Renal Denervation Technologies Market
EXHIBIT: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
Ageing Demographics to Propel the Demand for Renal Denervation Devices
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Rising Obesity Incidence Spurs the Demand for Renal Denervation Technologies Market
EXHIBIT: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Uptrend in Healthcare Spending Creates Fertile Environment
EXHIBIT 2: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
EXHIBIT 3: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
Regulatory Approvals to Remain a Focal Point
Breakthrough Designations for Renal Denervation Devices
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Renal Denervation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Radiofrequency Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Radiofrequency Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Ultrasound Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Ultrasound Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Micro-Infusion Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Micro-Infusion Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Renal Denervation Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
SPAIN
Spain Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2020 & 2027
Total Companies Profiled: 13

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com